Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
Title:
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
Author:
Wolinsky, Jerry S Arnold, Douglas L Brochet, Bruno Hartung, Hans-Peter Montalban, Xavier Naismith, Robert T Manfrini, Marianna Overell, James Koendgen, Harold Sauter, Annette Bennett, Iain Hubeaux, Stanislas Kappos, Ludwig Hauser, Stephen L